Trial ID | Maryland Oncology Hematology

Trial ID

Trial Information - Phase II

TAPISTRY: TUMOR-AGNOSTIC PRECISION IMMUNOONCOLOGYAND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL

Disease Specifics: (PIK3CA) (HER2+)(NTRK1/2/3) (AKT1/2/3)

Protocol ID: BO41932

Sponsor: Genentech, Inc.

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Breast

Investigator

Min MD, Frederick

Status

OPEN TO ENROLLMENT

Sponsor

Genentech, Inc.

« Clinical Trails Main

Quality Care Close to Home

View our locations on map!